The population of nitric oxide synthase-containing neurons persist in the ageing human retina.

E. Roufail,N. Bewick,S. Rees

DOI: https://doi.org/10.1111/J.1442-9071.1996.TB00999.X

1996-05-01

Abstract:

What problem does this paper attempt to address?

Monogenic leptin deficiency in early childhood obesity

Gehan ElSaeed,Noha Mousa,Fatma El-Mougy,Mona Hafez,Seham Khodeera,Mohamed Alhelbawy,Engy Fouda,Suzan Elsheikh,Rasha ElKaffas,Sara Eldeeb,Marwa Elsharkawy

DOI: https://doi.org/10.1111/ijpo.12574

Abstract:Background: Early childhood obesity is a public health problem worldwide. It affects different aspects of physical and mental child's health. Identifying the etiologies, especially treatable and preventable causes, can direct health professionals toward proper management. Analysis of serum leptin levels and leptin gene mutations is a rapid and easy step toward the diagnosis of congenital leptin deficiency that is considered an important cause in early childhood obesity. Objectives: The aim of this study was to diagnose monogenic leptin deficiency in Egyptian children presenting with early onset obesity (EOO). Methods: The current cross-sectional study included 80 children who developed obesity during the first year of life with BMI > 2 SD (for age and sex). The studied population was subjected to history taking, auxological assessment, serum leptin assay, and leptin gene sequencing. Results: Ten cases had leptin deficiency (12.5%), while 18 cases showed elevated leptin levels (22.5%). Leptin gene variants in the coding region were identified in 30% of the leptin-deficient group: two novel homozygous disease-causing variants (c.104 T > G and c.34 delC) and another previously reported homozygous pathogenic variant (c.313C > T). Conclusion: Leptin deficiency is considered a significant cause of monogenic obesity in Egyptian children with early-onset obesity as the diagnosis of these patients would be a perfect target for recombinant leptin therapy.
Dynamic exchange of (6, 73H) estradiol-17beta at the subcellular level in rat uterus.

R. de Hertogh,E. Ekka,I. Vanderheyden,J. Hoet

DOI: https://doi.org/10.1016/0022-4731(73)90054-X

1973-05-01

Journal of Steroid Biochemistry

Abstract:
Early onset obesity due to a mutation in the human leptin receptor gene

Carolina Chaves,Teresa Kay,João Anselmo

DOI: https://doi.org/10.1530/EDM-21-0124

2022-08-01

Abstract:Summary: Leptin is secreted by adipocytes in response to fat storage and binds to its receptor (LEPR), which is ubiquitously expressed throughout the body. Leptin regulates energy expenditure and is anorexigenic. In this study, we describe the clinical and hormonal findings of three siblings with a personal history of rapid weight gain during the first months of life. They had delayed puberty, high levels of FSH (15.6 ± 3.7 mUI/mL; reference: 1.5-12.4) and LH (12.3 ± 2.2 mUI/mL; reference: 1.7-8.6), normal oestradiol and total testosterone and successful fertility. None of the patients had dyslipidemia, diabetes or thyroid disease. Next-generation sequencing identified a pathogenic homozygous variant c.2357T>C, p.(Leu786Pro) in LEPR. Their parents and children were heterozygous for this mutation. We compared clinical and biochemical findings of homozygous carriers with first-degree heterozygous family members and ten randomly selected patients with adult-onset morbid obesity. Homozygous carriers of the mutation had significantly higher BMI (32.2 ± 1.7 kg/m2 vs 44.5 ± 7.1 kg/m2, P = 0.023) and increased serum levels of leptin (26.3 ± 9.3 ng/mL vs 80 ± 36.4 ng/mL, P = 0.028) than their heterozygous relatives. Compared with the ten patients with adult-onset morbid obesity, serum levels of leptin were not significantly higher in homozygous carriers (53.8 ± 24.1 ng/mL vs 80 ± 36.4 ng/mL, P = 0.149), and thus serum levels of leptin were not a useful discriminative marker of LEPR mutations. We described a rare three-generation family with monogenic obesity due to a mutation in LEPR. Patients with early onset obesity should be considered for genetic screening, as the identification of mutations may allow personalized treatment options (e.g. MC4R-agonists) and targeted successful weight loss. Learning points: The early diagnosis of monogenic forms of obesity can be of great interest since new treatments for these conditions are becoming available. Since BMI and leptin levels in patients with leptin receptor mutations are not significantly different from those found in randomly selected morbid obese patients, a careful medical history is mandatory to suspect this condition. Loss of leptin receptor function has been associated with infertility. However, our patients were able to conceive, emphasizing the need for genetic counselling in affected patients with this condition.
On some advanced nickel-based superalloys for disk applications

D. Locq,P. Caron

2011-11-01

Abstract:Recent works performed at ONERA on nickel-based superalloys for disk applications are presented. In the first section, disk characteristics and metallurgical routes used to produce these specific aero-engine components are reviewed. Then, two alloy development programmes carried out to satisfy the requirements of the industrial partners are detailed. Finally, the results of studies aiming at identifying the complex relationships linking the microstructure and the creep behaviour of disk superalloys are described: i) influence of the strengthening gamma prime precipitation on the deformation micromechanisms, and ii) effect of the microstructure on the grain boundary sliding.
Diabetic retinopathy: An overview for non-ophthalmologists

Q. Nguyen,D. Do

2003-04-01

Abstract:Nearly all patients with type 1 diabetes, and most with type 2 diabetes, eventually develop diabetic eye diseases, including diabetic retinopathy. Even in the advanced stages, diabetic retinopathy can be asymptomatic; yet it is the leading cause of new cases of blindness among working-age US adults. This article describes various ocular signs of diabetic retinopathy, such as microaneurysms, hard exudates, intraretinal hemorrhages, and cotton wool spots, all of which are visible on direct ophthalmoscopy and should trigger prompt consultation with an ophthalmologist. Referral of patients with diabetes to ophthalmologists for regular dilated eye examinations also is vital, as timely treatment can preserve vision in many patients. Additional ways in which physicians can help control or prevent progression of diabetic retinopathy include strict control of blood glucose, body weight, cholesterol, and blood pressure. A team approach to prevention and diagnosis gives patients with diabetes the best opportunity to preserve their vision. (Adv Stud Med. 2003;3(4):214-222)
Understanding the Genetics of Early-Onset Obesity in a Cohort of Children From Qatar

Idris Mohammed,Basma Haris,Tara Al-Barazenji,Dhanya Vasudeva,Sara Tomei,Iman Al Azwani,Hajar Dauleh,Saira Shehzad,Shiga Chirayath,Ghassan Mohamadsalih,Goran Petrovski,Amel Khalifa,Donald R Love,Mashael Al-Shafai,Khalid Hussain

DOI: https://doi.org/10.1210/clinem/dgad366

2023-11-17

Abstract:Context: Monogenic obesity is a rare form of obesity due to pathogenic variants in genes implicated in the leptin-melanocortin signaling pathway and accounts for around 5% of severe early-onset obesity. Mutations in the genes encoding the MC4R, leptin, and leptin receptor are commonly reported in various populations to cause monogenic obesity. Determining the genetic cause has important clinical benefits as novel therapeutic interventions are now available for some forms of monogenic obesity. Objective: To unravel the genetic causes of early-onset obesity in the population of Qatar. Methods: In total, 243 patients with early-onset obesity (above the 95% percentile) and age of onset below 10 years were screened for monogenic obesity variants using a targeted gene panel, consisting of 52 obesity-related genes. Results: Thirty rare variants potentially associated with obesity were identified in 36 of 243 (14.8%) probands in 15 candidate genes (LEP, LEPR, POMC, MC3R, MC4R, MRAP2, SH2B1, BDNF, NTRK2, DYRK1B, SIM1, GNAS, ADCY3, RAI1, and BBS2). Twenty-three of the variants identified were novel to this study and the rest, 7 variants, were previously reported in literature. Variants in MC4R were the most common cause of obesity in our cohort (19%) and the c.485C>T p.T162I variant was the most frequent MC4R variant seen in 5 patients. Conclusion: We identified likely pathogenic/pathogenic variants that seem to explain the phenotype of around 14.8% of our cases. Variants in the MC4R gene are the commonest cause of early-onset obesity in our population. Our study represents the largest monogenic obesity cohort in the Middle East and revealed novel obesity variants in this understudied population. Functional studies will be required to elucidate the molecular mechanism of their pathogenicity.
Transfer of Clostridium difficile Spores by Nonsporicidal Wipes and Improperly Used Hypochlorite Wipes Practice + Product = Perfection

J. Cadnum,Kelly N. Hurless,S. Kundrapu,C. Donskey

DOI: https://doi.org/10.1086/669871

2013-04-01

Abstract:To the Editor—Effective disinfection of contaminated surfaces is necessary to prevent transmission of Clostridium difficile spores. In addition to disinfection of rooms after discharge of patients with C. difficile infection (CDI), daily disinfection of surfaces may useful as a measure to decrease healthcare personnel hand contamination by reducing the burden of contamination on frequently touched surfaces.' Because C. difficile spores are resistant to killing by many disinfectants (eg, quaternary ammonium compounds), current guidelines recommend the use of sporicidal products such as sodium hypochlorite, particularly in outbreak or hyperendemic settings. In practice, it is not uncommon for healthcare facilities to use nonsporicidal products for some aspects of disinfection related to CDI (eg, daily cleaning of CDI rooms, equipment that may be damaged by exposure to hypochlorite). Rutala et al recently demonstrated that such use of nonsporicidal agents may be effective in reducing contamination on surfaces due to physical removal of spores (>2.9 log reduction). However, it is important for infection control practitioners to be aware that nonsporicidal wipes can transfer spores from contaminated to clean surfaces, and improper use of hypochlorite wipes can also reduce effectiveness. Here, we examined the potential for transfer of C. difficile spores by quaternary ammonium-impregnated wipes and by hypochlorite wipes used for longer than the recommended duration. Four wipes were tested: (1) Clorox premoistened germicidal wipes (Clorox), (2) used Clorox premoistened germicidal wipes (ie, a fresh wipe was used to wipe a clean surface area 25 ft long x 1 ft wide before testing, which resulted in drying within ~30 seconds after wiping a surface), (3) Kimtech Wet Task wipes (Kimberly-Clark) saturated with quaternary ammonium compound (VIREX II 256, JohnsonDiversey), and (4) Kimtech Wet Task wipes saturated with sterile water. The test organism was an epidemic North American pulsed-field gel electrophoresis type 1 isolate (VA 17). Spores were prepared as previously described. Transfer of spores was evaluated using a modification of the method of Williams et al. A clean bench top surface was inoculated with 5 log10 colony-forming unit (CFU) aliquots of C. difficile spores suspended in 10 /iL sterile water and allowed to air dry at room temperature for 30 minutes. The inoculation sites were manually wiped for 10 seconds with a wipe that was then sequentially wiped onto 4 clean sites for 10 seconds at each site. Each site was allowed 5 minutes of contact time before sampling with a sterile cotton-
Novel compound heterozygous mutations in LEP responsible for obesity in a Chinese family

Hui Li,Guodong Liu,Bei Lu,Xin Zhou

DOI: https://doi.org/10.1016/j.ymgmr.2024.101114

2024-06-29

Abstract:Background: Early childhood obesity poses a significant global public health challenge, necessitating the identification of treatable causes, particularly congenital leptin deficiencies. Serum leptin level measurement aids in diagnosing these rare contributors, guiding effective management. Methods: A Chinese family with early-onset obesity underwent LEP mutational screening via direct sequencing. mRNA expression and protein stability patterns of LEP were separately analyzed using qPCR and bioinformatics. Results: We present a case of a 12.5-year-old girl born to non-obese, non-consanguineous Chinese parents, exhibiting low leptin levels. Leptin gene sequencing revealed novel compound heterozygous mutations in exon 3. RT-PCR analysis showed the mutation didn't affect leptin production. Bioinformatics analysis indicated the variant rendered the leptin protein unstable. Conclusion: Loss-of-function mutations in LEP underlies early-onset obesity in the patient.
Classification of Congenital Leptin Deficiency

Julia von Schnurbein,Stefanie Zorn,Adriana Nunziata,Stephanie Brandt,Barbara Moepps,Jan-Bernd Funcke,Khalid Hussain,I Sadaf Farooqi,Pamela Fischer-Posovszky,Martin Wabitsch

DOI: https://doi.org/10.1210/clinem/dgae149

2024-03-12

The Journal of Clinical Endocrinology & Metabolism

Abstract:Abstract Purpose Bi-allelic pathogenic leptin gene variants cause severe early onset obesity usually associated with low or undetectable circulating leptin levels. Recently, variants have been described resulting in secreted mutant forms of the hormone leptin with either biologically inactive or antagonistic properties. Methods We conducted a systematic literature research supplemented by unpublished data from patients at our center as well as new in vitro analyses to provide a systematic classification of congenital leptin deficiency based on the molecular and functional characteristics of the underlying leptin variants and investigated the correlation of disease subtype with severity of the clinical phenotype. Results A total of 28 distinct homozygous leptin variants were identified in 148 patients. The identified variants can be divided into three different subtypes of congenital leptin deficiency: classical hormone deficiency (21 variants in 128 patients), biologically inactive hormone (3 variants in 12 patients) and antagonistic hormone (3 variants in 7 patients). Only 1 variant (n=1 patient) remained unclassified. Patients with biological inactive leptin have a higher percentage of 95th BMI percentile (%BMIp95) compared to patients with classical hormone deficiency. While patients with both classical hormone deficiency and biological inactive hormone can be treated with the same starting dose of metreleptin, patients with antagonistic hormone need a variant-tailored treatment approach to overcome the antagonistic properties of the variant leptin. Main conclusions Categorization of leptin variants based on molecular and functional characteristics helps to determine the most adequate approach to treatment of patients with congenital leptin deficiency.

endocrinology & metabolism
Novel homozygous leptin receptor mutation in an infant with monogenic obesity

Hiya Boro,Vikash Bundela,Velmurugan Mannar,Lakshmi Nagendra,Vinita Jain,Bimal Jain,Senthil Kumar,Sourabh Agstam

DOI: https://doi.org/10.5114/pedm.2023.129344

Abstract:Monogenic obesity can be caused by a mutation in one of the single genes involved in hunger and satiety. The most common mutations affect melanocortin 4 (MC4) followed by the leptin gene and its receptor. Leptin receptor (LEPR) gene mutation is an extremely rare endocrine disease characterized by early-onset obesity, hyperphagia in addition to pituitary hormone deficiency, and metabolic abnormalities. We report the case of a 12-month-old male infant born of a non-consanguineous marriage. He presented to us with rapid weight gain from 2 months of age along with hyperphagia. Biochemistry revealed a deranged lipid profile, elevated transaminases, and markedly raised serum leptin levels. On genetic analysis, a novel mutation was detected, which was a homozygous variation In exon 12 of the LEPR gene (chr1:g.65608901G>A) that resulted in the synonymous amino acid change of lysine at codon 584 proximal to donor splice site (p.Lys584). The in silico prediction of the variant was 'damaging' by MutationTaster2. The mutation was classified as a 'variant of uncertain significance' due to a lack of published literature and had to be correlated carefully with the clinical symptoms. It was recommended to do Sanger sequencing of the parents and other family members. However, due to financial constraints, the family could not afford the same. At the time of writing, funds were being arranged for procuring setmelanotide, which is a novel and effective therapy for monogenic obesity due to LepR mutation.
‘Blue eyes’ in newborn calves associated with bluetongue infection

M. Holzhauer,J. Vos

DOI: https://doi.org/10.1136/vr.164.13.403

2009-03-28

Abstract:EYE abnormalities are commonly diagnosed in bovine practice. Most cases are associated with bovine keratoconjunctivitis. This disorder is encountered in both dairy and beef calves, and in adult dairy cows. Moraxella bovis is most frequently isolated as the causal organism of bovine
Tests of Linkage And/or Association of the LEPR Gene Polymorphisms with Obesity Phenotypes in Caucasian Nuclear Families

YJ Liu,SMS Rocha-Sanchez,PY Liu,JR Long,Y Lu,L Elze,RR Recker,HW Deng

DOI: https://doi.org/10.1152/physiolgenomics.00213.2003

2004-01-01

Abstract:Genetic variations in the leptin receptor (LEPR) gene have been conceived to affect body weight in general populations. In this study, using the tests implemented in the statistical package QTDT, we evaluated association and/or linkage of the LEPR gene with obesity phenotypes in a large sample comprising 1,873 subjects from 405 Caucasian nuclear families. Obesity phenotypes tested include body mass index (BMI), fat mass, percentage fat mass (PFM), and lean mass, with the latter three measured by dual-energy X-ray absorptiometry (DXA). Three single nucleotide polymorphisms (SNPs), namely Lys109Arg (A/G), Lys656Asn (G/C), Pro1019Pro (G/A), in the LEPR gene were analyzed. Significant linkage disequilibrium (0.394 < or = |D'| < or = 0.688, P < 0.001) was observed between pairs of the three SNPs. No significant population stratification was found for any SNP/phenotype. In single-locus analyses, evidence of association was observed for Lys656Asn with lean mass (P = 0.002) and fat mass (P = 0.015). The contribution of this polymorphism to the phenotypic variation of lean mass and fat mass was 2.63% and 1.15%, respectively. Subjects carrying allele G at the Lys656Asn site had, on average, 3.16% higher lean mass and 2.71% higher fat mass than those without it. In the analyses for haplotypes defined by the three SNPs, significant associations were detected between haplotype GCA (P = 0.005) and lean mass. In addition, marginally significant evidence of association was observed for this haplotype with fat mass (P = 0.012). No statistically significant linkage was found, largely due to the limited power of the linkage approach to detect small genetic effects in our data sets. Our results suggest that the LEPR gene polymorphisms contribute to variation in obesity phenotypes.
A Novel Leptin Receptor LEPR Variant in a Toddler With Early-Onset Fatal Obesity

Kevin Perge,Linda Pons,Nastassja Protsenko,Delphine Collin-Chavagnac,Marc Nicolino

DOI: https://doi.org/10.1542/peds.2022-059569

2023-07-01

PEDIATRICS

Abstract:Monogenic obesity generally results in severe early-onset obesity associated with abnormal feeding behavior and endocrine disorders. We report here an extremely severe case of early-onset obesity associated with hyperphagia in an 11-month-old boy without other signs of a syndromic obesity. He developed severe obstructive sleep apnea, dyslipidemia, hepatic steatosis with cytolysis, and acanthosis nigricans with insulin resistance in the first months of life. Laboratory investigations showed an elevated serum leptin level (80.03 ng/mL, normal range 2.45-6.55 ng/mL). Next-generation sequencing of obesity genes panel identified a novel homozygous intronic variant in leptin receptor gene (LEPR), c.703 + 5G>A, predicting affected splicing that resulted in a frameshift, premature stop, and truncation of the protein beyond the cytokine receptor homology domain 1. The child died at 27 months of age in the absence of available specific drug therapy.
Genetic Causes of Severe Childhood Obesity: A Remarkably High Prevalence in an Inbred Population of Pakistan

Sadia Saeed,Muhammad Arslan,Jaida Manzoor,Sadia M Din,Qasim M Janjua,Hina Ayesha,Qura-Tul Ain,Laraib Inam,Stephane Lobbens,Emmanuel Vaillant,Emmanuelle Durand,Mehdi Derhourhi,Souhila Amanzougarene,Alaa Badreddine,Lionel Berberian,Stefan Gaget,Waqas I Khan,Taeed A Butt,Amélie Bonnefond,Philippe Froguel

DOI: https://doi.org/10.2337/db19-1238

IF: 7.7

Diabetes

Abstract:Monogenic forms of obesity have been identified in ≤10% of severely obese European patients. However, the overall spectrum of deleterious variants (point mutations and structural variants) responsible for childhood severe obesity remains elusive. In this study, we genetically screened 225 severely obese children from consanguineous Pakistani families through a combination of techniques, including an in-house-developed augmented whole-exome sequencing method (CoDE-seq) that enables simultaneous detection of whole-exome copy number variations (CNVs) and point mutations in coding regions. We identified 110 (49%) probands carrying 55 different pathogenic point mutations and CNVs in 13 genes/loci responsible for nonsyndromic and syndromic monofactorial obesity. CoDE-seq also identified 28 rare or novel CNVs associated with intellectual disability in 22 additional obese subjects (10%). Additionally, we highlight variants in candidate genes for obesity warranting further investigation. Altogether, 59% of cases in the studied cohort are likely to have a discrete genetic cause, with 13% of these as a result of CNVs, demonstrating a remarkably higher prevalence of monofactorial obesity than hitherto reported and a plausible overlapping of obesity and intellectual disabilities in several cases. Finally, inbred populations with a high prevalence of obesity provide unique, genetically enriched material in the quest of new genes/variants influencing energy balance.
Misuse of suxamethonium

A. Yoxall,K. Clarke,A. G. Warren

DOI: https://doi.org/10.1136/VR.102.3.66-A

1978-01-21

Abstract:
Congenital Leptin Deficiency and Leptin Gene Missense Mutation Found in Two Colombian Sisters with Severe Obesity

Hernan Yupanqui-Lozno,Raul A Bastarrachea,Maria E Yupanqui-Velazco,Monica Alvarez-Jaramillo,Esteban Medina-Méndez,Aida P Giraldo-Peña,Alexandra Arias-Serrano,Carolina Torres-Forero,Angelica M Garcia-Ordoñez,Claudio A Mastronardi,Carlos M Restrepo,Ernesto Rodriguez-Ayala,Edna J Nava-Gonzalez,Mauricio Arcos-Burgos,Jack W Kent Jr,Shelley A Cole,Julio Licinio,Luis G Celis-Regalado

DOI: https://doi.org/10.3390/genes10050342

2019-05-07

Abstract:Background: Congenital leptin deficiency is a recessive genetic disorder associated with severe early-onset obesity. It is caused by mutations in the leptin (LEP) gene, which encodes the protein product leptin. These mutations may cause nonsense-mediated mRNA decay, defective secretion or the phenomenon of biologically inactive leptin, but typically lead to an absence of circulating leptin, resulting in a rare type of monogenic extreme obesity with intense hyperphagia, and serious metabolic abnormalities. Methods: We present two severely obese sisters from Colombia, members of the same lineal consanguinity. Their serum leptin was measured by MicroELISA. DNA sequencing was performed on MiSeq equipment (Illumina) of a next-generation sequencing (NGS) panel involving genes related to severe obesity, including LEP. Results: Direct sequencing of the coding region of LEP gene in the sisters revealed a novel homozygous missense mutation in exon 3 [NM_002303.3], C350G>T [p.C117F]. Detailed information and clinical measurements of these sisters were also collected. Their serum leptin levels were undetectable despite their markedly elevated fat mass. Conclusions: The mutation of LEP, absence of detectable leptin, and the severe obesity found in these sisters provide the first evidence of monogenic leptin deficiency reported in the continents of North and South America.
OR33-03 Congenital Leptin Deficiency: Clinical Insights from the First Reported US Cases

Laura C Torchen,Beth Hakamy,Leo I Gordon,Erica E Marsh,Nabeel R Yaseen,Lisa M Neff

DOI: https://doi.org/10.1210/jendso/bvaa046.1059

2020-04-01

Journal of the Endocrine Society

Abstract:Abstract Background: Congenital leptin deficiency (CLD) is a rare autosomal recessive form of monogenic obesity caused by loss-of-function mutations in the leptin gene. Targeted therapy is available in the form of recombinant human leptin (metreleptin). Previous case series have reported dramatic weight loss and metabolic improvements with treatment, but metreleptin’s only FDA-approved indication is acquired generalized lipodystrophy (AGL). Metreleptin has a black box warning for risk of T-cell lymphoma, which has been reported in AGL patients, both treated and untreated with metreleptin. Clinical Case: Two sisters ages 18 yrs (sister A; BMI 45.2 kg/m2) and 20 yrs (sister B; 45.0 kg/m2) were referred for evaluation of obesity. They are of Pakistani origin with a family history of consanguinity. Birth weight was normal, but hyperphagia and excessive weight gain developed by age 3 months. They had been seen by endocrinologists, obesity specialists, and a geneticist during childhood but work-up for monogenic obesity was not pursued. They were treated with combination OCPs in adolescence due to primary amenorrhea and hypogonadotropic hypogonadism. Sister A was diagnosed with type 2 diabetes at age 15 years. Sister B had comorbidities of hydrocephalus s/p VP shunt, developmental delay, hyponatremia, autoimmune thyroid disease, growth hormone deficiency, and prediabetes. At the time of their present evaluation, serum leptin levels were obtained and were undetectable in both sisters. After discontinuing OCPs, testing confirmed hypogonadotropic hypogonadism. Both patients were homozygous for the pathogenic variant c398delG in exon 3 of the leptin gene (LEP), which causes a frameshift/premature stop codon. On MR elastography performed for hepatic steatosis, sister B had an incidental finding of axillary lymphadenopathy. Surgical biopsy and staging work-up confirmed diagnosis of nodular lymphocyte predominant Hodgkin lymphoma (a B cell lymphoma), Stage II disease. She was treated with R-ABVD with adjuvant radiation and achieved clinical remission, prior to treatment with metreleptin. The patients were enrolled in an observational treatment protocol, and responses to metreleptin therapy will be reported in future. Conclusion: To our knowledge, these are the first cases of CLD diagnosed in the U. S. In previous reports, CLD and other monogenic obesity disorders were prevalent among children with severe obesity in a consanguineous Pakistani population. Leptin deficiency should be considered in all patients with early onset obesity and hypothalamic amenorrhea. Furthermore, to our knowledge, this is the first report of lymphoma in a patient with CLD, occurring prior to any treatment with metreleptin. The risk for lymphoma associated with metreleptin may relate to preexisting autoimmune disease or immunologic abnormalities related to leptin deficiency rather than medication adverse effect.

English Else
Functional Characterization of Novel MC4R Variants Identified in Two Unrelated Patients with Morbid Obesity in Qatar

Idris Mohammed,Senthil Selvaraj,Wesam S Ahmed,Tara Al-Barazenji,Ayat S Hammad,Hajar Dauleh,Luis R Saraiva,Mashael Al-Shafai,Khalid Hussain

DOI: https://doi.org/10.3390/ijms242216361

2023-11-15

Abstract:The leptin-melanocortin pathway is pivotal in appetite and energy homeostasis. Pathogenic variants in genes involved in this pathway lead to severe early-onset monogenic obesity (MO). The MC4R gene plays a central role in leptin-melanocortin signaling, and heterozygous variants in this gene are the most common cause of MO. A targeted gene panel consisting of 52 obesity-related genes was used to screen for variants associated with obesity. Variants were analyzed and filtered to identify potential disease-causing activity and validated using Sanger sequencing. We identified two novel heterozygous variants, c.253A>G p.Ser85Gly and c.802T>C p.Tyr268His, in the MC4R gene in two unrelated patients with morbid obesity and evaluated the functional impact of these variants. The impact of the variants on the MC4R gene was assessed using in silico prediction tools and molecular dynamics simulation. To further study the pathogenicity of the identified variants, GT1-7 cells were transfected with plasmid DNA encoding either wild-type or mutant MC4R variants. The effects of allelic variations in the MC4R gene on cAMP synthesis, MC4R protein level, and activation of PKA, ERB, and CREB signaling pathways in both stimulated and unstimulated ɑ-MSH paradigms were determined for their functional implications. In silico analysis suggested that the variants destabilized the MC4R structure and affected the overall dynamics of the MC4R protein, possibly leading to intracellular receptor retention. In vitro analysis of the functional impact of these variants showed a significant reduction in cell surface receptor expression and impaired extracellular ligand binding activity, leading to reduced cAMP production. Our analysis shows that the variants do not affect total protein expression; however, they are predicted to affect the post-translational localization of the MC4R protein to the cell surface and impair downstream signaling cascades such as PKA, ERK, and CREB signaling pathways. This finding might help our patients to benefit from the novel therapeutic advances for monogenic forms of obesity.
Cyclic AMP.

I. Pastan

DOI: https://doi.org/10.1038/scientificamerican0872-97

Scientific American

Abstract:
Screening of 31 genes involved in monogenic forms of obesity in 23 Pakistani probands with early-onset childhood obesity: a case report

Robina Khan Niazi,Anette Prior Gjesing,Mette Hollensted,Christian Theil Have,Dmitrii Borisevich,Niels Grarup,Oluf Pedersen,Asmat Ullah,Gulbin Shahid,Ifrah Shafqat,Asma Gul,Torben Hansen

DOI: https://doi.org/10.1186/s12881-019-0886-8

2019-09-05

Abstract:Background: Consanguine families display a high degree of homozygosity which increases the risk of family members suffering from autosomal recessive disorders. Thus, homozygous mutations in monogenic obesity genes may be a more frequent cause of childhood obesity in a consanguineous population. Methods: We identified 23 probands from 23 Pakistani families displaying autosomal recessive obesity. We have previously excluded mutations in MC4R, LEP and LEPR in all probands. Using a chip-based, target-region capture array, 31 genes involved in monogenic forms of obesity, were screened in all probands. Results: We identified 31 rare non-synonymous possibly pathogenic variants (28 missense and three nonsense) within the 31 selected genes. All variants were heterozygous, thus no homozygous pathogenic variants were found. Two of the rare heterozygous nonsense variants identified (p.R75X and p.R481X) were found in BBS9 within one proband, suggesting that obesity is caused by compound heterozygosity. Sequencing of the parents supported the compound heterozygous nature of obesity as each parent was carrying one of the variants. Subsequent clinical investigation strongly indicated that the proband had Bardet-Biedl syndrome. Conclusions: Mutation screening in 31 genes among probands with severe early-onset obesity from Pakistani families did not reveal the presence of homozygous obesity causing variants. However, a compound heterozygote carrier of BBS9 mutations was identified, indicating that compound heterozygosity must not be overlooked when investigating the genetic etiology of severe childhood obesity in populations with a high degree of consanguinity.

The population of nitric oxide synthase-containing neurons persist in the ageing human retina.

Monogenic leptin deficiency in early childhood obesity

Dynamic exchange of (6, 73H) estradiol-17beta at the subcellular level in rat uterus.

Early onset obesity due to a mutation in the human leptin receptor gene

On some advanced nickel-based superalloys for disk applications

Diabetic retinopathy: An overview for non-ophthalmologists

Understanding the Genetics of Early-Onset Obesity in a Cohort of Children From Qatar

Transfer of Clostridium difficile Spores by Nonsporicidal Wipes and Improperly Used Hypochlorite Wipes Practice + Product = Perfection

Novel compound heterozygous mutations in LEP responsible for obesity in a Chinese family

Classification of Congenital Leptin Deficiency

Novel homozygous leptin receptor mutation in an infant with monogenic obesity

‘Blue eyes’ in newborn calves associated with bluetongue infection

Tests of Linkage And/or Association of the LEPR Gene Polymorphisms with Obesity Phenotypes in Caucasian Nuclear Families

A Novel Leptin Receptor LEPR Variant in a Toddler With Early-Onset Fatal Obesity

Genetic Causes of Severe Childhood Obesity: A Remarkably High Prevalence in an Inbred Population of Pakistan

Misuse of suxamethonium

Congenital Leptin Deficiency and Leptin Gene Missense Mutation Found in Two Colombian Sisters with Severe Obesity

OR33-03 Congenital Leptin Deficiency: Clinical Insights from the First Reported US Cases

Functional Characterization of Novel MC4R Variants Identified in Two Unrelated Patients with Morbid Obesity in Qatar

Cyclic AMP.

Screening of 31 genes involved in monogenic forms of obesity in 23 Pakistani probands with early-onset childhood obesity: a case report